Results 81 to 90 of about 25,204 (165)

Integrating ctDNA-based ESR1m monitoring into first-line care for ER+, HER2- advanced breast cancer: a consensus workflow. [PDF]

Oncologist
Abdou Y, Cipriani A, Feinstein T, Haumschild R, Mardones M, Mortimer J, Vail E.   +6 more
europepmc   +1 more source

Nivolumab in patients with advanced solid tumors with ctDNA-defined high blood tumor mutational burden: a phase II trial. [PDF]

ESMO Open
Nakamura Y, Esaki T, Nishina T, Shinozaki E, Taniguchi H, Kato T, Komatsu Y, Yuki S, Kato K, Wakabayashi M, Ikeno T, Ishiguro Y, Takahashi K, Ikeda Y, Asano M, Sato A, Kuwata T, Yoshino T.   +17 more
europepmc   +1 more source

Minimal residual disease combined with radiological tumor volume as a tool for identification of resected NSCLC patients at high risk of recurrence. [PDF]

J Liq Biopsy
Verzè M, Minari R, Bordi P, Bocchialini G, Martines G, Pluchino M, D'Agnelli S, Gnetti L, Cosenza A, Balestra V, Ampollini L, Leo L, Milanese G, Roberti C, Gallani C, Hayes J, Malapelle U, Tiseo M.   +17 more
europepmc   +1 more source

Genetics of mCRPC tracked in ctDNA [PDF]

Nature Reviews Clinical Oncology, 2016
openaire   +1 more source

Postoperative circulating tumor DNA in stage II colon cancer: biological rationale, clinical evidence, and unresolved challenges. [PDF]

Front Oncol
Yang E, Wang X, Zhang J, Zhao D, Yang Z, Li X, He G, Guo T, Wang R, Yuan B.   +9 more
europepmc   +1 more source

Prognostic Value and Longitudinal Dynamics of Multigene Circulating Tumor DNA in Advanced Pancreatic Cancer Treated with 5-Fluorouracil-Based Chemotherapy. [PDF]

Int J Mol Sci
Lee GY, Chun JW, Lee DE, Jang JH, Lee WJ, Kim HP, Lee ST, Woo SM, Kong SY.   +8 more
europepmc   +1 more source

ctDNA identified in patients with CUP [PDF]

Nature Reviews Clinical Oncology, 2017
openaire   +1 more source

Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial. [PDF]

J Clin Oncol
Subramanian A, Nouth SCL, Nemat-Gorgani N, Soudi S, Ballman KV, Heise RS, Johns C, Sears TJ, Roohani S, Krcek R, Hong AM, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Mowery YM, Kirsch DG, Moding EJ.   +17 more
europepmc   +1 more source

The prospects and challenges of the use of cell-free DNA as a diagnostic and prognostic biomarker for oral cancer in Sub-Saharan Africa. [PDF]

J Liq Biopsy
Bolfrey DA, Temilola DO, Boamah MO, Parkins GE, Chetty M.   +4 more
europepmc   +1 more source

Analysis of cell-free DNA in lymphomas: from sample collection to genotyping and minimal residual disease monitoring. [PDF]

Blood Adv
Piffaretti D, Consoli C, Rossi D.
europepmc   +1 more source